MRD / Regn No. : 20260000401 Date : 13/07/2026
Patient Name : Goutam Dutta Age & Gender : 58 Yrs. / Male
Contact No. : 8167621456 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : NAFLD (14/May/2026) | A3G3 DKD (14/May/2026) |
Subjective : DM FOR 16 YEARS,DKD
Objective : NONE
Analysis : TYPE 2 DM,MILD TSH ELEVATION,A3G3 DKD,DR CHANGES IN FUNDUS,STT CHANGES,VITAMIN D DEFICIENCY,NORMAL TMT,F0S2 MASLD
Plan : INCREASE SEMAGLUTIDE TO 0.5 MG,SEE ME IN 1 MONTH  
Salient Investigations : CREATININE: 1.63 mg/dL | FASTING PLASMA GLUCOSE (FPG): 170 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 263 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 46.54 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 46.54 mL/min/1.73m2 | CHLORIDE: 100.52 meq/L | POTASSIUM: 4.05 meQ/L | SODIUM: 132.53 meq/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
2 TABLET FINERONONE 10 MG
KERENDIA
Medicine For DIABETIC KIDNEY DISEASE 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
3 INJECTION SEMAGLUTIDE 0.5 MG
SUNDAE 0.5 MG
Medicine For DIABETES HEART KIDNEY PROTECTION 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
MAY CAUSE GI OR VISUAL DISTURBANCES
       
Refill : 0 / Substitution:    
Education :
Next Visit : 12/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP BUN CR ELECTROLYTES
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: